Arkolith/Insider Trading/HRMY/Form 4

Zaeske Adam H.

CHIEF COMMERCIAL OFFICERHarmony Biosciences Holdings, Inc. (HRMY) · full profile →Form 4 · filed Apr 9, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 7, 2026Option exercise(M)8K—$08K
Apr 7, 2026Tax withholding(F)3K$27.62$88K4K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 7, 2026Option exercise(M)8K—$08K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002064712-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML